Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide: an Interventional Prospective Study
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 01 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 19 May 2015 Planned initiation date changed from 1 Dec 2014 to 1 Aug 2015, according to to ClinicalTrials.gov record.